Summary
GlobalData's clinical trial report, “Vitiligo Global Clinical Trials Review, H2, 2018" provides an overview of Vitiligo clinical trials scenario. This report provides top line data relating to the clinical trials on Vitiligo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Centre Hospitalier Universitaire de Nice
Clinuvel Pharmaceuticals Ltd
Alkem Laboratories Ltd
Astellas Pharma Inc
Novartis AG
Incyte Corp
Avemedica sro
Applied Biology Inc
Aclaris Therapeutics Inc
Ache Laboratorios Farmaceuticos SA
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Vitiligo to Dermatology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Vitiligo to Dermatology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Vitiligo Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profile Snapshots 34
Appendix 108
Abbreviations 108
Definitions 108
Research Methodology 109
Secondary Research 109
About GlobalData 109
Contact Us 110
Source 110
List of Tables
Vitiligo Therapeutics, Global, Clinical Trials by Region, 2018* 7
Vitiligo Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Vitiligo Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Vitiligo Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Vitiligo Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Vitiligo Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Vitiligo Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Vitiligo Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Vitiligo to Dermatology Clinical Trials, G7 Countries (%), 2018* 16
Vitiligo Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Vitiligo Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Vitiligo to Dermatology Clinical Trials, E7 Countries (%), 2018* 19
Vitiligo Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Vitiligo Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Vitiligo Therapeutics, Global, Clinical Trials by Phase, 2018* 22
Vitiligo Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23
Vitiligo Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Vitiligo Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
Vitiligo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
Vitiligo Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 28
Vitiligo Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Vitiligo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Vitiligo Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33
List of Figures
Vitiligo Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Vitiligo Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Vitiligo Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Vitiligo Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Vitiligo Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Vitiligo Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Vitiligo Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Proportion of Vitiligo to Dermatology Clinical Trials, G7 Countries (%), 2018* 16
Vitiligo Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Vitiligo Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Vitiligo to Dermatology Clinical Trials, E7 Countries (%), 2018* 19
Vitiligo Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Vitiligo Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Vitiligo Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
Vitiligo Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23
Vitiligo Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Vitiligo Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
Vitiligo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
Vitiligo Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 28
Vitiligo Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29
Vitiligo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31
Vitiligo Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33
GlobalData Methodology 109
